2017
DOI: 10.1007/s10545-017-0113-8
|View full text |Cite
|
Sign up to set email alerts
|

Coagulopathy in Zellweger spectrum disorders: a role for vitamin K

Abstract: IntroductionZellweger spectrum disorders (ZSDs) are caused by an impairment of peroxisome biogenesis, resulting in multiple metabolic abnormalities. This leads to a range of symptoms, including hepatic dysfunction and coagulopathy. This study evaluated the incidence and severity of coagulopathy and the effect of vitamin K supplementation orally and IV in ZSD.MethodsData were retrospectively retrieved from the medical records of 30 ZSD patients to study coagulopathy and the effect of vitamin K orally on protein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 16 publications
0
8
0
Order By: Relevance
“…Multiple reports on characterization and natural history of clinical findings in individuals with ZSD provided important information on the wide spectrum of manifestations in this disorder [ 14 , 16 , 17 , 18 , 20 ]. However, few identify the common clinical findings specific to disease severity categories and selected proxies for disease severity have been variable across studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Multiple reports on characterization and natural history of clinical findings in individuals with ZSD provided important information on the wide spectrum of manifestations in this disorder [ 14 , 16 , 17 , 18 , 20 ]. However, few identify the common clinical findings specific to disease severity categories and selected proxies for disease severity have been variable across studies.…”
Section: Discussionmentioning
confidence: 99%
“…Patients diagnosed with ZSD present with extensive clinical heterogeneity and symptoms across multiple organs as a result of decreased or absent peroxisome function. Clinical manifestations include low muscle tone, facial dysmorphisms, impaired growth, sensory and neurological dysfunction, renal and endocrine insufficiency, skeletal abnormalities, and developmental delays [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Vitamin K deficiency is partly corrected by administering vitamin K therapy orally. 22 Currently, there are no curative options for ZSD patients.…”
Section: Discussionmentioning
confidence: 99%
“…These issues can be partially alleviated through oral or IV vitamin K supplementation, which improves overall vitamin K status and blood clotting capabilities [72,73]. Individuals with cystic fibrosis or those undergoing anticoagulant therapy are at increased risk for vitamin K deficiency, affecting coagulation and elevating the risk of bleeding during dental procedures.…”
Section: Oral Manifestations Of Vitamin K Deficiencymentioning
confidence: 99%